Clarius Group’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
Clarius Group's BSX Position: Q4 2025 in Review
Clarius Group reduced its Boston Scientific (BSX) stake by 0.03% in Q4 2025, selling an estimated $196 and leaving 7,987 shares worth $762K. The position accounts for 0.04% of the portfolio, ranked #151.
Clarius Group first reported a position in BSX in Q1 2019 and has held it in 28 quarters since. The position peaked at $1.16M in Q1 2025. 1,802 funds tracked by Wall St. Rank hold BSX as of Q4 2025.
- Clarius Group held 7,987 shares of Boston Scientific worth $762K as of Q4 2025.
- Clarius Group sold 2 Boston Scientific shares in Q4 2025, an estimated $196.
- Boston Scientific made up 0.04% of Clarius Group's portfolio in Q4 2025, its #151 holding.
- Clarius Group first reported a position in Boston Scientific in Q1 2019 and has held it in 28 quarters since.
- Clarius Group's Boston Scientific position peaked at $1.16M in Q1 2025.
- 1,802 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.
Based on Clarius Group's 13F filing for Q4 2025, filed 14 Jan 2026.